Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ThePresident
    Member
    • Jun 2012
    • 72

    Bowtie default parameters

    Hello,

    I have a very simple question about bowtie:

    If I run bowtie without explicitly specifying the mode, the default mode should be used (which is -n mode), right? Now, if I don't specify neither the number of mismatches (-N) nor seed length (-L), what are the default parameters for N and L then?

    Thank you in advance,

    TP
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    For bowtie2

    -N <int> max # mismatches in seed alignment; can be 0 or 1 (0)
    -L <int> length of seed substrings; must be >3, <32 (22)

    N = 0 and L = 22.
    Presets: Same as:
    For --end-to-end:
    --very-fast -D 5 -R 1 -N 0 -L 22 -i S,0,2.50
    --fast -D 10 -R 2 -N 0 -L 22 -i S,0,2.50
    --sensitive -D 15 -R 2 -N 0 -L 22 -i S,1,1.15 (default)
    --very-sensitive -D 20 -R 3 -N 0 -L 20 -i S,1,0.50

    For --local:
    --very-fast-local -D 5 -R 1 -N 0 -L 25 -i S,1,2.00
    --fast-local -D 10 -R 2 -N 0 -L 22 -i S,1,1.75
    --sensitive-local -D 15 -R 2 -N 0 -L 20 -i S,1,0.75 (default)
    --very-sensitive-local -D 20 -R 3 -N 0 -L 20 -i S,1,0.50

    Comment

    • ThePresident
      Member
      • Jun 2012
      • 72

      #3
      Yeah, that's for bowtie 2. I used the original version of bowtie. I wonder if they kept the same default parameters...

      Comment

      • mastal
        Senior Member
        • Mar 2009
        • 666

        #4
        The default values of n and l for bowtie are different.

        See the bowtie manual

        Comment

        • GenoMax
          Senior Member
          • Feb 2008
          • 7142

          #5
          N and L are not valid options for bowtie 1.0 (but n and l are)

          -n/--seedmms <int> max mismatches in seed (can be 0-3, default: -n 2)
          -e/--maqerr <int> max sum of mismatch quals across alignment for -n (def: 70)
          -l/--seedlen <int> seed length for -n (default: 28)

          Comment

          • ThePresident
            Member
            • Jun 2012
            • 72

            #6
            Originally posted by GenoMax View Post
            N and L are not valid options for bowtie 1.0 (but n and l are)
            Darn, I was looking at wrong place... Anyway, thanks alot!

            TP

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              Yesterday, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 11:10 AM
            0 responses
            8 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            30 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            39 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            25 views
            0 reactions
            Last Post SEQadmin2  
            Working...